OTC · MDGEF
Medigene AG
$2.59$0.00 (0.0%)
Medigene AG’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · STMM · USD
Stock price
Quote as of Apr 8, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Stemcell Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Stemcell Holdings, Inc., primarily operating through its subsidiary Stemcell Co., Ltd., specializes in the regenerative medicine sector. The company provides crucial technical support for the cultivation, storage, and delivery of stem cells, alongside administrative and consulting services for clinics. It offers two distinct stem cell regenerative therapies: autologous mesenchymal stem cells derived from adipose tissue and natural killer cells. To facilitate its stem cell culturing activities, Stemcell Holdings coordinates patient introductions to clinics, manages scheduling, and provides translation services to overcome language barriers between patients and medical professionals. Additionally, the firm offers internet marketing solutions, specifically search engine optimization for clinics, and engages in property and equipment rental. Founded in Tokyo, Japan, in 2015, the company was formerly known as Perfect Acquisition, Inc. before changing its name to Stemcell Holdings, Inc. in January 2016. As of May 2, 2016, Stemcell Holdings, Inc. operates as a subsidiary of Primavera Singa Pte Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.59$0.00 (0.0%)
Medigene AG’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$17.15+$1.53 (+9.8%)
Galera Therapeutics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 42.83% below the high.
$0.02$0.00 (0.0%)
United American Healthcare Corporation’s quoted price sits in the lower half of its reported 52-week range, 30.77% below the high.
$0.00$0.00 (0.0%)
Health Sciences Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.75$0.00 (0.0%)
Vaccinex, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Neon Bloom, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.56% below the high.
$0.00$0.00 (0.0%)
Resonate Blends, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.6% below the high.
$0.00$0.00 (0.0%)
Pressure BioSciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.75% below the high.
